信息搜索
信息关键字:泰
 

共有2177条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109]

·连续“20cm”涨停!泰林生物:截至三季度NC膜销售收入仅91万元;深交所:是否存在配合二级市场炒作2022-11-30 9:20:33
·否极泰来空间打开2022-11-30 9:19:47
·联泰环保控股股东联泰集团质押8300万股用于自身生产经营2022-11-30 0:38:43
·海泰新光股东欧奈尔中心减持477.6万股套现3.97亿2022年前三季度公司净利1.4亿2022-11-29 22:16:10
·成发泰达科创板IPO审核状态变更为“终止” 海南航空是公司应收账款第一大客户2022-11-29 19:57:12
·泰林生物收关注函:说明公司NC膜产品满产情况下预测收入2022-11-29 19:48:47
·上交所:终止成发泰达科创板IPO审核2022-11-29 19:48:45
·成发泰达科创板IPO终止2022-11-29 18:12:13
·中泰化学:托克逊能化拟申请3亿元流动资金贷款公司控股股东将为其提供担保2022-11-29 15:03:32
·智翔金泰首发事项获通过 将加快产业化基地建设2022-11-29 14:25:57
·11月29日新股提示:欧普泰等申购光华股份等公布中签率2022-11-29 12:46:40
·创新抗体生物制药企业智翔金泰科创板过会2022-11-29 12:03:49
·创新抗体生物制药企业智翔金泰科创板过会2022-11-29 9:44:10
·重庆第二家!智翔金泰科创板IPO过会,拟募资39.8亿元2022-11-28 22:45:13
·[新股]助力国产创新药全球竞技 智翔金泰科创板过会2022-11-28 20:43:08
·智翔金泰首发获科创板上市委通过 公司尚未盈利且存在累计未弥补亏损2022-11-28 20:09:12
·智翔金泰首发获得通过2022-11-28 20:00:37
·智翔金泰科创板IPO过会 募资39.8亿加码抗体药物研发2022-11-28 19:12:50
·科创板上市委:智翔金泰首发获通过2022-11-28 19:12:30
·科创板上市委:智翔金泰首发获通过2022-11-28 18:51:45

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109]